Regulation of MITF stability by the USP13 deubiquitinase

Nature Communications

Volumn 2, Issue 1, 2011, Pages

  Zhao, Xiansi ^a   Fiske, Brian ^a   Kawakami, Akinori ^a   Li, Juying ^a   Fisher, David E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; MESSENGER RNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PROTEINASE; SHORT HAIRPIN RNA; UBIQUITIN SPECIFIC PROTEASE 13; UNCLASSIFIED DRUG; MITF PROTEIN, HUMAN; USP13 PROTEIN, HUMAN;

AGAR MEDIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; TUMOR CELL LINE; UBIQUITINATION; UPREGULATION;

MUS MUSCULUS;

CELL LINE, TUMOR; ENDOPEPTIDASES; HUMANS; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; UBIQUITINATION; UP-REGULATION;

EID: 79961200772     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1421     Document Type: Article

References (35)

1. Levy, C., Khaled, M. & Fisher, D. E. MITF: Master regulator of melanocyte development and melanoma oncogene. Trends Mol. Med. 12, 406-414 (2006). (Pubitemid 44291572)
2. Lin, J. Y. & Fisher, D. E. Melanocyte biology and skin pigmentation. Nature 445, 843-850 (2007).
3. Garraway, L. A. et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117-122 (2005). (Pubitemid 40966196)
4. Du, J. et al. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell 6, 565-576 (2004). (Pubitemid 40017700)
5. McGill, G. G. et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109, 707-718 (2002). (Pubitemid 34722267)
6. Huber, W. E. et al. A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes. J. Biol. Chem. 278, 45224-45230 (2003). (Pubitemid 37432656)
7. Price, E. R. et al. alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J. Biol. Chem. 273, 33042-33047 (1998). (Pubitemid 28557700)
8. Bertolotto, C. et al. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J. Cell Biol. 142, 827-835 (1998). (Pubitemid 28381498)
9. Widlund, H. R. & Fisher, D. E. Microphthalamia-associated transcription factor: A critical regulator of pigment cell development and survival. Oncogene 22, 3035-3041 (2003). (Pubitemid 36713753)
10. Jacquemin, P., Lannoy, V. J., O'Sullivan, J., Read, A., Lemaigre, F. P. & Rousseau, G. G. The transcription factor onecut-2 controls the microphthalmia-associated transcription factor gene. Biochem. Biophys. Res. Commun. 285, 1200-1205 (2001). (Pubitemid 32912908)
11. Yasumoto, K., Takeda, K., Saito, H., Watanabe, K., Takahashi, K. & Shibahara, S. Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. EMBO J. 21, 2703-2714 (2002). (Pubitemid 34619386)
12. Saito, H. et al. Melanocyte-specific microphthalmia-associated transcription factor isoform activates its own gene promoter through physical interaction with lymphoid-enhancing factor 1. J. Biol. Chem. 277, 28787-28794 (2002).
13. Davis, I. J. et al. Oncogenic MITF dysregulation in clear cell sarcoma: Defining the MiT family of human cancers. Cancer Cell 9, 473-484 (2006). (Pubitemid 43832189)
14. Hemesath, T. J., Price, E. R., Takemoto, C., Badalian, T. & Fisher, D. E. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature 391, 298-301 (1998). (Pubitemid 28099019)
15. Wu, M. et al. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev. 14, 301-312 (2000). (Pubitemid 30106485)
16. Brummelkamp, T. R., Nijman, S. M., Dirac, A. M. & Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424, 797-801 (2003). (Pubitemid 37021711)
17. Popov, N. et al. The ubiquitin-specific protease USP28 is required for MYC stability. Nat. Cell Biol. 9, 765-774 (2007). (Pubitemid 47019463)
18. Xu, W. et al. Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp. Cell Res. 255, 135-143 (2000). (Pubitemid 30143848)
19. Miller, A. J., Du, J., Rowan, S., Hershey, C. L., Widlund, H. R. & Fisher, D. E. Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma. Cancer Res. 64, 509-516 (2004). (Pubitemid 38120889)
20. Gray-Schopfer, V., Wellbrock, C. & Marais, R. Melanoma biology and new targeted therapy. Nature 445, 851-857 (2007).
21. Wellbrock, C., Rana, S., Paterson, H., Pickersgill, H., Brummelkamp, T. & Marais, R. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS ONE 3, e2734 (2008).
22. Murakami, H. & Arnheiter, H. Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. Pigment Cell Res. 18, 265-277 (2005). (Pubitemid 41032886)
23. Zhu, P. et al. A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation. Mol. Cell 27, 609-621 (2007). (Pubitemid 47238636)
24. Joo, H. Y. et al. Regulation of cell cycle progression and gene expression by H2A deubiquitination. Nature 449, 1068-1072 (2007).
25. Kerscher, O., Felberbaum, R. & Hochstrasser, M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 22, 159-180 (2006).
26. Timms, K. M., Ansari-Lari, M. A., Morris, W., Brown, S. N. & Gibbs, R. A. The genomic organization of Isopeptidase T-3 (ISOT-3), a new member of the ubiquitin specific protease family (UBP). Gene 217, 101-106 (1998). (Pubitemid 28427312)
27. Popov, N., Herold, S., Llamazares, M., Schülein, C. & Eilers, M. Fbw7 and Usp28 regulate myc protein stability in response to DNA damage. Cell Cycle. 6, 2327-2331 (2007). (Pubitemid 350058681)
28. Zhang, D., Zaugg, K., Mak, T. W. & Elledge, S. J. A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. Cell 126, 529-542 (2006). (Pubitemid 44163600)
29. Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D. & Courtois, G. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424, 801-805 (2003). (Pubitemid 37021712)
30. Sun, S. C. & Ley, S. C. New insights into NF-kappaB regulation and function. Trends Immunol. 29, 469-478 (2008).
31. McGill, G. G., Haq, R., Nishimura, E. K. & Fisher, D. E. c-Met expression is regulated by Mitf in the melanocyte lineage. J. Biol. Chem. 281, 10365-10373 (2006). (Pubitemid 43864575)
32. Ferguson, C. A. & Kidson, S. H. The regulation of tyrosinase gene transcription. Pigment Cell Res. 10, 127-138 (1997). (Pubitemid 127523199)
33. Deeds, J., Cronin, F. & Duncan, L. M. Patterns of melastatin mRNA expression in melanocytic tumors. Hum. Pathol. 31, 1346-1356 (2000).
34. Duncan, L. M. et al. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res. 58, 1515-1520 (1998). (Pubitemid 28193617)
35. Zhao, X., Patton, J. R., Davis, S. L., Florence, B., Ames, S. J. & Spanjaard, R. A. Regulation of nuclear receptor activity by a pseudouridine synthase through posttranscriptional modification of steroid receptor RNA activator. Mol. Cell 15, 549-558 (2004). (Pubitemid 39141782)